Pacira Biosciences
PCRX
EPS for Pacira Biosciences (PCRX)
EPS in 2023 (TTM): $0.14
According to Pacira Biosciences 's latest financial reports the company's current EPS (TTM) is $0.14. In 2022 the company made an earnings per share (EPS) of $0.35 a decrease over its 2021 EPS that were of $0.95.
EPS history for Pacira Biosciences from 2010 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $0.14 | -60% |
| 2022 | $0.35 | -63.16% |
| 2021 | $0.95 | -71.89% |
| 2020 | $3.38 | -1351.85% |
| 2019 | -$0.27 | 1250% |
| 2018 | -$0.02000 | -98.17% |
| 2017 | -$1.09 | 7.92% |
| 2016 | -$1.01 | -2611.25% |
| 2015 | $0.04022 | -110.05% |
| 2014 | -$0.40 | -79.27% |
| 2013 | -$1.93 | 11.56% |
| 2012 | -$1.73 | -37.99% |
| 2011 | -$2.79 | -92.13% |
| 2010 | -$35.43 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Omeros Corporation OMER | $0.64 | 357.14% | 🇺🇸 USA |
 Heron Therapeutics HRTX | -$1.17 | -935.71% | 🇺🇸 USA |
 Cara Therapeutics
CARA | -$2.06 | -1,571.43% | 🇺🇸 USA |